This is an easy read document about the standard. The standard is to help everyone know how and when to use psychotropic medicines.

This fact sheet explains some actions for consumers and/or their carers take to help keep safe while using insulin. Insulins are available in different strengths and formulations or presentations with medicine names that look and sound similar. Consumers need to ‘stop, think and check’ that they have the right brand of insulin in the right...

A presentation from Professor Jennifer Martin on a Clinician’s perspective on managing medicines for an ageing population. 

A presentation from Ms Alice Nugent on Digital tools for medicines management in Aboriginal Community Controlled Health Organisations.

A presentation by Mr Bronte Parkin on Polypharmacy Consumer Perspective.

This issue includes items on health services operations management, person-centred care, environmental sustainability, medication safety, digital health, palliative care, and more. Along with the latest from BMJ Quality & Safety, Australian Prescriber, Australian Journal of Primary Health, Joint Commission Journal on Quality and Patient...

This resource accompanies the Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard. It describes what the quality statements mean for healthcare services and provides indicators to support local quality improvement activity.

This factsheet highlights best practise dispensing to support safe and quality use of insulin, within the context of active ingredient prescribing. Safe and quality use of insulins requires clear information transfer from initial prescribing to the dispensing label, to ensure safe use by consumers and/or their carers.